FDA clears Novo Nordisk's weight loss drug Saxenda
The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss.
Dec 23, 2014
0
1
The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss.
Dec 23, 2014
0
1
After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy—a formulation expressly designed to help users shed pounds—sales of both drugs skyrocketed.
Jun 26, 2023
0
8
Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday.
Jan 9, 2023
0
38
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
Nov 19, 2015
0
15
Health care professionals and organizations need to respond more forcefully to unethical marketing from the pharmaceutical industry by holding offending companies to greater account and by supporting stronger regulation, ...
Sep 19, 2023
1
79
In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.
Nov 13, 2023
0
0
Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.
May 5, 2023
0
2
(HealthDay)—Ozempic (semaglutide) has been approved by the U.S. Food and Drug Administration as a weekly injection to treat type 2 diabetes in adults.
Dec 6, 2017
0
4
The burden of diabetes is increasing globally. There are about half a billion people in the world living with the disease. In sub-Saharan Africa, 23 million people had diabetes in 2021. This number is expected to increase ...
Nov 22, 2021
0
53
In what is believed to be the first study of its kind, new UVA Health research reveals that a factory-calibrated continuous glucose monitor (CGM) may be sufficiently accurate for use by people on dialysis, a group often plagued ...
Jun 29, 2022
0
10